UCB's Global Corporate Website
Welcome to UCB in the United States

Feb

22

Rare Disease Day 2024: The Moment is Now to Be Patient-First to Deliver for People Living with Rare Diseases

Feb

12

Harmony in Health: Partnering for Enhanced Seizure Management and Understanding

Jan

11

Our Wish in 2024: Renewed Hope for People Living with Chronic Inflammatory Diseases

Dec

01

Media Statement on levetiracetam (KEPPRA® and KEPPRA XR®) and DRESS

Nov

27

UCB's Commitment to Diversity, Equity, and Inclusion: Partnering at AES for a Better Future

Oct

18

Evolving Expectations for Dermatological Conditions

Oct

17

Steadfast Towards Our Ambition to Create a UCB Rare Disease Portfolio

Sep

12

Disease Spotlight: Thymidine Kinase 2 Deficiency (TK2d)

Sep

11

UCB PharmD Second-Year Fellows Share Reflections and Advice

Aug

28

Breaking Down the Value Chain: Patient Voices Advocating for Change